Table 2.
Echocardiographic data of left ventricular function at the end of four weeks
| Group | LVEF (%) | LVFS (%) | LVIDd (mm) | LVIDs (mm) | LVESV (mm) | MAPSE (mm) |
|---|---|---|---|---|---|---|
| Sham | 72.100±1.646 | 40.100±1.338 | 3.130±0.050 | 1.876±0.059 | 10.890±0.878 | 0.661±0.025 |
| AngII | 47.920±1.970* | 23.590±1.199* | 3.631±0.060* | 2.773±0.054* | 28.940±1.381* | 0.467±0.011* |
| AngII+LIPUS | 65.160±1.021 | 34.440±0.709 | 2.970±0.066 | 1.948±0.059 | 11.990±0.952 | 0.619±0.017 |
| AngII+LIPUS+pp2 | 56.590±1.931# | 28.940±1.267# | 3.505±0.098# | 2.494±0.100# | 23.940±2.133# | 0.531±0.016# |
The results are presented as mean±standard error of the mean (SEM), n>3 per group. * P<0.05 vs. the sham group; # P<0.05 vs. the AngII+LIPUS group. AngII, angiotensin II; LIPUS, low-intensity pulsed ultrasound; pp2, pyrazolopyrimidine 2; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVIDd, left ventricular internal diameters at end diastole; LVIDs, left ventricular internal diameters at end systole; LVESV, left ventricle end-systolic volume; MAPSE, mitral annular plane systolic excursion.